Clinical Performance of a Phakic Intraocular Lens (IOL)

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

July 9, 2019

Study Completion Date

July 9, 2019

Conditions
Presbyopia
Interventions
DEVICE

EDOF ICL

The Visian ICL is intended to be implanted within the posterior chamber, directly behind the iris, and in front of the anterior capsule of the human crystalline lens. It offers an intraocular alternative for the correction of refractive error in those who currently utilize spectacle and/or contact lenses correction.

Trial Locations (6)

20012

Innova Ocular Begitek, San Sebastián

33012

Instituto Oftalmológico Fernández-Vega, Oviedo

B-2610

Mediopolis, Antwerp

04120

Qvision-Hospital Vithas Virgen del Mar, Almería

08035

IMO Instituto de Microcirugía Ocular, Barcelona

01005

Clínica Oftalmológica Gasteiz, Vitoria-Gasteiz

All Listed Sponsors
lead

Staar Surgical Company

INDUSTRY

NCT03499821 - Clinical Performance of a Phakic Intraocular Lens (IOL) | Biotech Hunter | Biotech Hunter